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The  HLA genetic  loci  in  the  major histocompatibility  complex  (MHC) 1 of man 
control  the  expression  of several  cell  surface  molecules  that  play  a  central  role  in 
intercellular communication in the immune system. The HLA-A, -B, and -C antigens 
are composed of a 44,000-dalton glycoprotein, which is MHC encoded, and a  12,000- 
dalton protein,  identified  as f12 microglobulin, which does not map in the MHC  (1). 
The HLA-D locus of the human MHC  maps to the left of HLA-B on chromosome 6 
(map  order:  centromere,  D,  B,  C,  A).  HLA-D is  the  primary  locus responsible  for 
stimulation  in the mixed  lymphocyte reaction  (MLR),  which is  thus used  to define 
HLA-D specificities  (2).  A  second  weak  MLR  stimulatory  locus  may be  linked  to 
HLA-A (3, 4). The HLA-D locus is also linked to disease susceptibility (5) and controls 
immune  responses  to  certain  antigens  (6).  The  serologically  defined  HLA-DR  (D 
related)  locus is closely linked or identical to the HLA-D locus. Serological typing of 
HLA-DRw specificities shows a strong correlation with HLA-Dw types, although the 
DRw typing is generally broader than that of Dw (5).  In addition, HLA-DR antisera 
can block stimulation  in the MLR  (I,  7).  HLA-DR controls the expression  of a  cell 
surface molecule  (DR)  with a  more limited  tissue  distribution  than  the  HLA-A, -B, 
and  -C  antigens.  These  DR  antigens  are  found  predominantly  on  B  cells  and 
monocytes, although  they have also been detected  on limited  types of other normal 
and neoplastic cells  (7, 8), most notably on activated T  cells  (9-11). 
The  DR  molecule  is  composed  of  two  noncovalently  linked  glycoproteins  of 
apparent 33,000-35,000 mol wt (DR heavy or a-chain or p34) and 27,000-29,000 mol 
wt (DR light or fl-chain or p29)  (1).  The HLA-D/DR  region appears to be equivalent 
to  the  I  region  of the  murine  and  guinea  pig  MHC.  These  I  regions,  which  are 
composed of several genetic subregions, control the primary stimulatory determinants 
in the MLR, determine  immune  responsiveness  to certain  antigens,  and control the 
expression of several cell surface glycoproteins (Ia antigens)  similar in structure to the 
DR antigens  (12). 
Serologically,  the  HLA-A,  -B,  and  -C  antigens  and  the  HLA-DR  antigens  are 
polymorphic.  Within  the  human  population,  >20  alleles  of the  HLA-A locus  and 
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>30 alleles of the HLA-B locus have been defined (5). HLA-A and -B heavy chains 
(44,000-dahon subunit) carrying different serologic determinants are structurally very 
similar to each other, displaying 80% homology in their amino acid sequences (13). It 
has been demonstrated that  serologically different HLA-A and -B heavy chains can 
be  distinguished  by  isoelectric focusing  (14).  By  this  method,  each  of the  different 
heavy chains displayed microheterogeneity, in part due to a  difference in sialic acid 
content  (14). The smaller subunit, f12 microglobulin,.is invariant. 
Eight alleles of the HLA-DR  locus have been well established and the existence of 
others is indicated (5). In this study, the structural basis for the serologically detected 
polymorphism in HLA-DR  antigens and the variability of each subunit were inves- 
tigated.  The  DR  antigens  were  isolated  from human  B  lymphoblastoid  cell  lines 
homozygous  for  HLA-DR  and  were  compared  by  sodium  dodecyl  sulfate  (SDS)- 
polyacrylamide gel electrophoresis (SDS-PAGE) and isoelectric focusing (IEF). Lim- 
ited  structural  polymorphism  was  demonstrated  for  the  murine  Ia  subunits  using 
these techniques  (15-17).  Nonglycosylated forms of the HLA-DR  polypeptide chains 
were  also compared to determine  if the carbohydrate contributed  to the structural 
polymorphism or microheterogeneity. 
Materials  and  Methods 
Cells.  Human  B lymphoblastoid cell lines were obtained from the Genetics Laboratory of 
Oxford  University, Oxford,  England.  The  cell line  23.1 was established in  this laboratory. 
These  long-term  cell  lines were  established by  transformation  of normal  peripheral blood 
lymphocytes with Epstein-Barr virus. The HLA-Dw and -DRw specificities were determined as 
part of the 7th International Histocompatibility Workshop,  1977, Oxford, England. The cell 
lines were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum (tbs), 
100 U/ml penicillin, and 100 btg/ml streptomycin (all from Grand Island Biological Co., Grand 
Island, N. Y.). 
Preparation of Labeled  Cell Extracts.  Before labeling, the cells were preincubated for  1-2 h at 
37°C  in RPMI-1640  medium  lacking methionine and supplemented with  10%  dialyzed tbs, 
penicillin, and streptomycin to deplete the intracellular methionine pool. The cells (2 X  106) 
were centrifuged and resuspended at a concentration of 1 X  106/ml in the methionine-deficient 
medium  described above.  In  some  experiments, cultures were  supplemented  with  2 /lg/ml 
tunicamycin (a gift from Eli Lilly and Co., Indianapolis, Ind.) and incubated at 37°C for an 
additional 45 min. All cultures were then supplemented with 0.25 mCi [~6S]methionine (New 
England Nuclear, Boston,  Mass.;  >500  Ci/mmol)  and  incubated  for  12-16  h  at  37°C.  The 
labeled cells were harvested by centrifugation, washed, and added to 2 ×  106 unlabeled cells. 
The  membrane  proteins  were  extracted  by  detergent  solubilization  in  1  ml  lysis  buffer 
containing 0.5%  Nonidet P-40  (NP-40;  Particle Data, Inc., Elmhurst, Ill.), 0.01  M  Tris-HCl, 
pH  7.6,  1 mM  MgC12, and 0.1  mM  phenylmethylsulfonylfluoride (Sigma Chemical Co., St. 
Louis, Mo.). The suspension was incubated on  ice for 30 min  followed by centrifugation at 
100,000 g for 1 h. The supernatant fraction was recovered and stored at -70°C until use. 
Neuraminidase  Treatment.  A sample (100 btl) of NP-40 cell extract was diluted 1:1 with 0.1 M 
sodium acetate, pH 5.5,  1.8% NaCI, and 0.2% CaC12 and divided into two aliquots. Neuramin- 
idase  (Vibrio  cholerae, 500  U/ml;  Calbiochem-Behring Corp.,  American  Hoechst  Corp.,  San 
Diego, Calif.) was added to one aliquot in four additions of 5 U  each, over the course of the 
incubation, to give a  final concentration of 140  U/ml. The aliquot with and without  neura- 
minidase was incubated at 37°C for a total of 8-9 h. The reaction was stopped by freezing the 
sample at -70°C before immunoprecipitation. 
Antisera  and Immunoprecipitation.  The antisera used were all prepared in rabbits by James F. 
Kaufman, Harvard University, Cambridge, Mass. These included anti-p29,34 serum, which is 
directed against the native DR complex, and anti-p29 and anti-p34 sera, which are directed 
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by James F.  Kaufman as described elsewhere  (18,  19).  Briefly, the DR complex p29,34, was 
extracted  from  B  lymphoblastoid cell  membranes by detergent  solubilization and  partially 
purified by lentil-lectin affinity chromatography.  The  complex was  isolated  by preparative 
SDS-PAGE of an unboiled sample. The separated chains were  isolated by preparative SDS- 
PAGE after boiling the sample in the presence of SDS. 
The protein A-bearing bacterium Staphylococcus aureus Cowan I strain (SaCI) was used as an 
immunoadsorbent and was prepared as described by Kessler (20).  The SaCI was used as a  10% 
(vol/vol) solution and added in a  10-fold excess (vol/vol) over the amount of antiserum used to 
precipitate the antigens. 
The radiolabeled detergent cell extracts were pretreated  for  1 h on ice with normal rabbit 
serum (NRS)  followed by a  30-min incubation with the immunoadsorbent. This cleared the 
solution of biosynthetically labeled immunoglobulins and proteins adsorbing nonspecifically. 
The  extract  was  centrifuged  to  remove  the  immunoadsorbent.  The  supernate  was  then 
incubated with the specific antiserum followed by SaCI as described above. If the anti-p29 or 
anti-p34 sera were to be used, the cell extract was made 1% in SDS, boiled for 5 rain and cooled 
on ice before the incubation with the antiserum. After the incubations, the immunoadsorbent 
was washed extensively by repeated centrifugation and resuspension in the following buffers: 
two times in NET buffer (0.15 M  NaC1, 5 mM EDTA, 50 mM Tris-HCl, pH  7.5, and 0.02% 
sodium azide)  supplemented with  1% NP-40,  1 mg/ml ovalbumin and NaCI to give a  final 
concentration of 0.5 M; three times in the same buffer with the NP-40 concentration reduced 
to 0.5%; and two times in NET buffer. The immunoprecipitated proteins were eluted from the 
immunoadsorbent by boiling the sample for 5 min in Laemmli gel (21)  sample buffer (0.0625 
M  Tris-HCl, pH  6.8,  10%  glycerol,  5%  2-mercaptoethanol, and 0.001%  bromophenol blue) 
containing 2% SDS followed by centrifugation to remove the SaCI. 
Antibody Binding  to Cell Surface.  To determine whether certain proteins were present on the 
cell surface,  antiserum was  incubated with  intact cells before detergent  lysis and the results 
were  compared  to  those obtained by immunoprecipitation from  detergent extracts.  1 ×  l06 
cells were labeled for 16 h at a concentration of 5 ×  105 cells/ml with 0.25 mCi aSS-methionine 
as described previously. The labeled cells were harvested and washed two times with Dulbecco's 
phophate-buffered saline (PBS; GIBCO). The cells were resuspended in 300 #1 PBS and divided 
into two aliquots. The control aliquot of cells was lysed by the addition of 300/ll of lysis buffer 
containing an extract of 3 ×  106 unlabeled cells. The labeled cell extract was incubated for 30 
min on ice followed by a  30 min centrifugation at  12,000 g  at 4°C. The supernate was then 
used for immunoprecipitations using NRS and anti-p29,34 serum as described in the previous 
section. The experimental aliquot of intact labeled cells was incubated with 10/11 of anti-p29,34 
serum for  1 h  on ice. The unbound antibodies were removed by washing the cells twice with 
PBS and the cells were then lysed by the addition of 300 #1 of lysis buffer containing 3 X  106 
unlabeled  cells  and  centrifuged  as  described  for  the  control  aliquot.  The  supernate  was 
incubated with 100 #l SaCI to precipitate the immune complexes followed by centrifugation to 
remove the immunoadsorbent. The supernate of this precipitation was used for a second round 
of immunoprecipitation with NRS and anti-p29,34 serum. The immunoadsorbent with bound 
antibody-antigen complexes was treated as described in the previous section. 
Gel Electrophoresis.  Samples were separated according to molecular weight by discontinuous 
SDS-PAGE  as  described  by  Laemmli  (21).  The  gels  contained a  7-15%  linear acrylamide 
gradient.  Molecular  weight  standards  used  were  bovine serum  albumin  (68,000  mol  wt), 
ovalbumin (43,000 mol wt), papain-solubilized HLA-A and -B heavy chain (34,000 tool wt), 
carbonic anhydrase from bovine erythrocytes (29,000 mol wt), trypsin (23,300 mol wt), and ,82 
microglobulin (12,000 mol wt). Protein molecular weight markers were d:.nsylated according 
to the procedure of Talbot and Yphantis (22). Electrophoretic grade gel reagents were purchased 
from  Bio-Rad  Laboratories  (Richmond,  Calif.).  Tris  base and  glycine were  obtained from 
Sigma Chemical Co. 
IEF was  performed  in slab  gels of dimension 25  cm  X  10.5  cm  X  1 mm.  Proteins were 
electrophoresed across the width of the gel. An LKB  2117 Multiphor flat bed gel apparatus 
(LKB  Instruments, Inc., Rockville, Md.)  was employed which was attached  to a  circulating 
water bath to maintain the temperature at  7°C. The IEF gels contained 8 M  urea (Absolute 
grade; Research Plus Laboratories, Inc., Denville, N. J.), 2% NP-40 (vol/vol), 7% acrylamide, 
0.19% N,N'-methylenebis-acrylamide, and 2%  (wt/vol) Ampholine carrier ampholytes (LKB DEBORAH  A. SHACKELFORD AND JACK L.  STROMINGER  147 
Instruments, Inc.). The proportions of the individual ampholytes are described in the figure 
legends. The urea was dissolved fresh and deionized with  Rexyn 300  (Fisher Scientific Co., 
Pittsburgh,  Pa.)  before use. Gels were polymerized with  0.025%  ammonium  persulfate and 
0.0005%  N,N,N',N'-tetramethylenediamine.  The  wick  solutions  were  1  M  NaOH  for  the 
cathode and  1 M  phosphoric acid for the anode. 
Two-Dimensional Gel Electrophoresis.  Two-dimensional (2-D) gel electrophoresis was carried 
out as described by Singer et al. (23) with modifications. In the first dimension, samples were 
separated by SDS-PAGE as described above. The appropriate molecular weight region was cut 
out  of the  gel. Two  methods were  used  to  excise the  gel pieces depending on  the  type of 
comparison to be made. 
MethodA.  Radiolabeled samples and dansylated protein markers were loaded in alternating 
wells in the SDS-polyacrylamide  gel. After the gel was electrophoresed, the dansylated proteins 
were visualized with ultraviolet light. Each lane containing a radiolabeled sample was excised. 
The molecular weight region from 28,000 to 36,000 and from 41,000 to 44,000 daltons was cut 
out of the lane. 
Method B.  Alternatively, radiolabeled  samples were applied to adjacent wells and dansylated 
protein markers were loaded in the outside wells. In this case, a band corresponding to a more 
limited molecular weight range was cut out horizontally across all lanes containing radiolabeled 
samples. 
With either method, the excised gel strips were equilibrated for 2 h at room temperature in 
a solution of 6 M deionized urea, 2% NP-40, and 0.2% pH 9-11 Ampholines. The gel piece was 
then laid directly on the surface of the IEF gel along the wick at the anode. Excess solution was 
blotted off the gel piece and a glass strip was laid on top of it to prevent movement of the gel 
piece. The IEF gel was electrophoresed for 7-8 h at  1,000 V. 
The pH gradient was measured with a Corning flat surface combination electrode (Corning 
Glass Works,  Science Products  Div., Corning,  N.  Y.).  In  addition,  protein standards  with 
known isoelectric points (pI) and patterns were used. These included soybean trypsin inhibitor, 
/~-lactoglobin, and equine and whale myoglobin. 
The gel was fixed for 30 min at 60°C in 0.9 M  trichloroacetic acid and 0.2 M  5-sulfosalicylic 
acid. Protein standards were stained at 60°C in 0.04% Coomassie Brilliant Blue G250 and 2.1% 
perchloric acid and  destained at room temperature in 5% acetic acid, 7% ethanol, and  10% 
ethyl acetate (24). 
The  IEF and  SDS-polyacrylamide gels were  fluorographed as  described by Bonnet  and 
Laskey (25). 
Results 
Comparison  of DR  Antigens by  SDS-PAGE.  Human  B  lymphoblastoid  cell  lines 
homozygous for HLA-D and -DR were chosen for study and are described in Table 
I. To compare different DR products, the cell lines were metabolically labeled with 
[35S]methionine. The cells were lysed and membrane proteins were extracted with the 
nonionic  detergent  NP-40.  The  DR  antigens  were  immunoprecipitated with  a  xe- 
noantiserum directed against the p29,34 DR complex and analyzed by SDS-PAGE as 
shown in Fig. 1. The antiserum recognized four major bands. These included the DR 
heavy chain (p34) of an apparent 34,000-35,000  mol wt and the DR light chain (p29) 
with  an  apparent  30,000-32,000  mol  wt.  The  heavy  chain  appeared  to  migrate 
similarly in all cell lines tested. However, the light chain varied in its electrophoretic 
mobility depending on the DR type of the cell line from which it was derived. 
Two additional bands of apparent 33,000  and  32,000  mol wt  and designated M1 
and M2, respectively, were also precipitated with anti-p29,34 serum. Their molecular 
weights appeared similar in all cell lines. The proteins M 1 and M2 can be dissociated 
from the DR complex by several methods. If the NP-40 cell extract was incubated at 
37°C before immunoprecipitation, the anti-p29,34 serum precipitated mainly the DR 
heavy and  light chain  (see Fig. 4A).  Alternatively, washing the  immunoadsorbent- 148  STRUCTURAL  POLYMORPHISM  OF HLA-DR ANTIGENS 
TABLE I 
HLA  Types of Human B Lymphoblastoid Cell Lines 
HLA type 
Cell line 
A  B  Cw  Dw*  DRw~: 
IBW4  3,3  35,35  4  1,1  1,1 
METTE  2,3  5,18  1,1  1,(1) 
MST  3,3  7,7  2,2  2,2 
PGF  3,3  7,7  2,2  2,2 
LKT  1,1  8,8  3,3  3,3 
WT20  30,30  18,18  5  0  3,3 
PRIESS  2,2  15,15  3  4,4  4,4 
MICH  2,32  27,15  2  0  5,(5) 
ARENT  2,2  38,39  6,6  6,(6) 
MANN  29,29  l 2,12  4  7,7  7,7 
JMF  23,23  12,12  4  7,7  7,(7) 
MADURA  2,2  40,40  3  8,8  8,8 
23.1§  2,2  27,27  1  8,8  8,8 
* 0 indicates not typed. 
:~ The numbers within parentheses indicate preliminary typing. 
§The  donor  for this  cell  line  was  typed by Dr.  B.  G.  Solheim, Tissue  Typing 
Laboratory, University Hospital, Oslo, Norway. 
bound antibody-DR antigen complex with 0.1% SDS removed most of M 1 (data not 
shown). 
Actin  has  been  shown  to  be  a  major component  of purified  human  lymphocyte 
membranes and is a  common contaminant  of immunoprecipitates from lymphocyte 
extracts  (26,  27).  In  Fig.  1,  the  band  with  apparent  44,000  mol  wt  migrated  as 
expected for actin (42,000-44,000  daltons) and it had a  similar pI as will be shown in 
the next section. It was seen in all immunoprecipitations including those using NRS. 
It has been demonstrated that the heavy and light chains of DR  antigens are cell 
surface glycoproteins. To determine if M1  and M2  are accessible at the cell surface, 
intact  radiolabeled  cells  were  incubated  with  anti-p29,34  serum  as  described  in 
Methods. After this incubation, the unbound antibody was removed by washing the 
cells which  were  then  lysed in  the presence of a  sixfold excess of unlabeled cells to 
prevent  the  immunoprecipitation  of  newly  accessible  intracellular  proteins.  The 
immune complexes were precipitated with SaCI. The results are presented in Fig. 2. 
Lane 2 demonstrates that when the antibody has access only to the outside of the cell, 
the predominant proteins recognized are the DR heavy and light chains and M2 but 
not  M1.  After the incubation of the antiserum with  the intact cells, detergent  lysis, 
and precipitation with SaCI, the supernate was used for a  second round of immuno- 
precipitation with anti-p29,34 serum to reveal possible intracellular proteins. Lane 3 
(Fig. 2) shows that M1  and some additional heavy and light chains are precipitated 
from the detergent cell extract after removal of the cell surface DR antigens. 
Comparison  of DR  Antigens by  2-D  Gel  Electrophoresis.  The  extent  of  structural 
polymorphism among  allelic products of HLA-DR  was  further  investigated by 2-D 
gel electrophoresis. In this procedure, SDS-PAGE was used in the first dimension and 
IEF was used in the second dimension. Because most of the proteins of interest were 
not  water  soluble,  NP-40  was  included  in  the  IEF  gel.  This  prevented  the  direct 
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Ftc.  1.  Fluorograph of SDS-polyacrylamide gel of DR antigens which were immunoprecipitated 
from  35  NP-40 extracts of [  S]methionine-labeled cell  lines using anti-p29,34 serum. The cell  lines 
used were IBW4 (lane 1), MST (lane 2), LKT (lane 3), PRIESS  (lane 4), MICH  (lane 5), ARENT 
(lane 6), MANN (lane 7)  and MADURA.(lane 8). The lane number in this figure corresponds to 
the DRw type of the cell line. The indicated bands are A, actin;  H, DR heavy chain; and L, DR 
light chain. MI and M2 are described in the text. 
FIG.  2.  Fluorograph of SDS-polyacrylamide gel demonstrating accessibility of DR antigens at cell 
surface. Lane 1  : control immunoprecipitate from cell extract using anti-p29,34 serum. Lane 2: intact 
cells were incubated with anti-p29,34 serum and then lysed in the presence of unlabeled cells and 
the  immune complexes were  precipitated  with  SaCI  (experimental  immunoprecipitate).  Lane  3: 
immunoprecipitate  from  cell  extract  using anti-p29,34  serum  after  removal  of the  cell  surface 
antigens as described for lane 2. Lane 4: immunoprecipitation from cell extract using NRS. The cell 
line used was LKT. The indicated bands are IgG heavy (y)  and light (~) chains. The other bands 
are described in the legend to Fig.  1. 150  STRUCTURAL  POLYMORPHISM  OF  HLA-DR  ANTIGENS 
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described  by Singer et al.  (23),  because the SDS apparently formed mixed micelles 
with  the  NP-40  which  migrated  to  the  anode,  effectively clearing  the  IEF  gel  of 
detergent.  It was found that equilibrating the SDS-polyacrylamide gel strips in 6 M 
urea and 2% NP-40 and applying the strips at the anode overcame this problem. 
Fig. 3 shows a comparison of the 2-D gel patterns of the DR antigens immunopre- 
cipitated from eight cell lines. After the first-dimension gel was electrophoresed, the 
lanes were cut out as described for method A  in the region corresponding to 28,000- 
36,000 daltons. Limiting the area of the SDS-polyacrylamide gel excised allowed the 
application of multiple samples to one IEF gel facilitating the direct  comparison of 
several cell  lines.  The area corresponding to actin  (41,000-44,000  daltons)  was also 
cut  out  of the  gel  because  this  protein  provided  a  reference  point  in  the  second 
dimension. 
Several structural features of the DR antigens are revealed by comparing different 
specificities by  2-D  gels.  Both  the  DR  heavy and  light  chains  focused  as  multiple 
bands,  possibly caused  by heterogeneity in  post-translational  modifications such  as 
glycosylation or phosphorylation.  The  heavy chain  focused as  a  cluster of three  to 
four prominent  bands around  pI 5.4-5.7.  No major differences in  the pattern  were 
noted  among alt  cell  lines  tested.  In  contrast,  the  DR  light  chains  generated  IEF 
patterns consisting of three  to seven major bands  ranging in  pI  from 6.5  to 8.  The 
pattern  varied considerably among cell  lines expressing different  DRw specificities. 
Therefore, although both the DR heavy and light chains display microheterogeneity 
within  the product of a  single allele, only the light chain shows structural  polymor- 
phism among the products of different alleles. 
The DRw 4 specificity cross-reacts serologically with DRw 5 and 7 specificities (5) 
and  the  2-D gel patterns of these three DR light  chains  also show similarities.  The 
DR light  chains  isolated  from the cell lines  PRIESS  (DRw4),  MICH  (DRw5), and 
MANN (DRw7)  each focused as a  band at pI 7, two major bands at pI 6.8 and 6.6, 
and a  minor,  more acidic band.  A  second  minor spot  at  pI  7 was apparent  for the 
DRw 5 light chain but not for DRw 4 or 7. The 2-D pattern of the light chain from 
MADURA  (DRw8)  was similar to that of DRw  7 but shifted to a  more acidic pH. 
The  light  chains  from  the  cell  lines  ARENT  (DRw6)  and  MST  (DRw2)  both 
exhibited a complex 2-D pattern consisting of at least seven bands. The DRw 6 light 
chain pattern appeared to consist of at least two clusters of bands; one cluster of three 
to four bands resembled the DRw 7 light chain pattern and the second cluster of four 
spots was more basic and less  intensely labeled. The most basic light chain was that 
isolated from LKT (DRw3) which had a cluster of about four spots at a pI of 7.3-7.6. 
The 2-D gel pattern of several cell lines expressing the same DRw specificity were 
compared to look for differences not correlating with the HLA-D/DR type. This type 
of analysis revealed no major differences in the DR heavy and light chains among cell 
lines  sharing  DRw  specificities  whether  or  not  they  shared  HLA-A,  -B,  and  -C 
specificities.  For example, DR  antigens  isolated  from IBW4  and  METTE  (DRwl) 
generated  the  same 2-D pattern,  as did  MST  and  PGF  (DRw2),  LKT and  WT20 
(DRw3),  MANN  and JMF  (DRw7),  and  MADURA  and  23.1  (DRw8)  (data  not 
shown). 
The  protein  M1  had  a  pl  of ~7.4.  It  appeared  as  one  major spot  but  may be 
resolved into more than one band  (Fig.  3,  MANN).  The M2 protein appeared as a 
faint spot at pI 8.3.  It was most evident in the 2-D gel pattern of ARENT (Fig. 3), but DEBORAH A.  SHACKELFORD AND JACK L.  STROMINGER  153 
it was present in all cell lines. The M 1 and M2 proteins appeared invariant in all cell 
lines tested. 
The band (44,000 daltons)  identified as actin from the first-dimension gel focused 
as two closely spaced spots at ~pI 5.8. It has been shown that there are two forms of 
non-muscle cell actin which can be distinguished  by IEF and have a  pI of 5.4  (28). 
Neuraminidase Treatment of DR Antigens.  The  DR light  and  heavy chains  have an 
average sialic acid content of 2.2 and 2.6 tool per mol respectively (29).  In Fig. 3, the 
increasing  acidity  of the  heavy  chain  bands  was  accompanied  by  an  increasing 
apparent  molecular  weight  consistent  with  an  increasing  sialic  acid  content.  To 
further investigate the source of the microheterogeneity within each allele of the DR 
heavy and light  chains,  labeled cell extracts were incubated  with  neuraminidase to 
remove terminal sialic acids.  The DR antigens were then  immunoprecipitated with 
anti-p29,34  serum  and  separated  by  SDS-PAGE.  Fig.  4A  demonstrates  that  after 
incubation  with  neuraminidase,  the  apparent  molecular  weights  of both  the  DR 
heavy and light chains decreased, consistent with the removal ofsialic acids. As noted 
earlier,  incubation  at  37°C  in  the  presence or  absence of the  enzyme leads  to  the 
disappearance of most of M 1 and M2. 
Fig. 4B shows the 2-D gel patterns of several DR antigens after incubation at 37°C 
with or without neuraminidase. In this experiment, bands were excised from the SDS- 
polyacrylamide gel as described in method B. A band corresponding to 36,000-32,000 
daltons was cut out across several lanes, as was the subjacent band corresponding to 
32,000-29,000  daltons, and both were applied to the IEF gel. This procedure allowed 
a more direct comparison of polypeptides of a given molecular weight from different 
cell lines. 
After neuraminidase treatment the DR heavy chain was shifted to a more basic pI 
consistent with the removal of sialic acids. However, even after an extensive treatment 
with neuraminidase,  the heavy chain pattern was not collapsed to a  single band.  A 
similar  pattern  was  observed  for all  cell  lines  analyzed.  The  DR  light  chain  also 
became more basic after neuraminidase treatment, and did not collapse into a single 
band. The light chains of different DRw specificities still differed in their pI, despite 
removal  of sialic  acids.  Thus  sialic  acid  differences  cannot  account  for  structural 
polymorphism among the products of different HLA-DR alleles. 
Effect of Tunicamycin on DR Antigens.  The structural  polymorphism between  light 
chains  of different  DR  specificities  could  be a  result  of differences  in  amino  acid 
sequence or in the oligosaccharide moieties. In the last section, it was demonstrated 
that  some of the  microheterogeneity within,  but  not  polymorphism among,  allelic 
specificities was a  result of variability in the number of sialic acid residues. To study 
the role of the rest of the carbohydrate in determining structural polymorphism, cell 
lines were metabolically labeled in the presence oftunicamycin. Tunicamycin prevents 
the addition  of N-linked carbohydrate to protein  by inhibiting  the  formation of N- 
acetylglucosamine-lipid intermediates (30, 31). 
Figs. 5 and 6 show that under the conditions used, the amounts of glycosylated DR 
heavy and light chains were reduced and new bands appeared at ~29,000 and 27,000- 
28,000  daltons.  These  bands  are  presumably  nonglycosylated  forms  of  the  DR 
polypeptides.  Xenoantisera  directed  against  the  separated  heavy and  light  chains 
were  used  to  analyze  the  relationship  of  these  nonglycosylated  chains  to  their 
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heavy chain,  as expected  (Fig.  5, lane  3), and  also recognized  the new 29,000-dalton 
polypeptide  (Fig.  5,  lanes  8-15).  This new  species,  isolated  from eight  different  cell 
lines, migrated  identically  (Fig.  5). The anti-p29 serum precipitated  the glycosylated 
light  chain  (30,000-32,000  tool  wt,  Fig.  5,  lane  2  and  Fig.  6)  and  the  new  band 
migrating at 27,000-28,000  dahons  (Fig. 5, lanes 5, 7 and Fig. 6). Some variability in 
the  electrophoretic  mobility  of this  new  protein  was observed  when  different  DRw 
specificities were compared  (Fig.  6, lanes 5-8).  Thus tunicamycin  appears to convert 
the DR heavy chain  to a  species of apparent  29,000  mol wt and the light chain  to a 
species of apparent  27,000-28,000  mol wt. It was noted that the anti-p29 serum could 
also precipitate some of the DR heavy chain  (Fig. 5, lanes 2, 7). This was probably a 
result of incomplete separation of the chains because it was not consistently observed 
(Fig. 6). In some cell lines, additional  bands between 27,000  and 30,000  daltons were 
precipitated  by anti-p29,34  serum, but  these were not recognized by antisera against 
the separated chains. 
The glycosylated and nonglycosylated forms of the DR antigens were compared by 
2-D gels. The antigens precipitated  from one cell line by anti-p29,34  serum were cut 
out of the first-dimension  gel by method A  to include  the molecular weight  range of 
24,000 to 36,000 daltons and then analyzed by IEF. Fig. 7 A shows that after removal 
of the  N-linked  glycan  chains,  the  heavy and  light  chains  each  became  more basic 
and focused as two bands. 
The DR antigens  from tunicamycin-treated  cells were also precipitated  with anti- 
p29 or anti-p34  sera after boiling in SDS to separate the chains  as described  earlier. 
The  immunoprecipitated  proteins  were  separated  in  the  first  dimension  by  SDS- 
PAGE  and  excised  for IEF as described  in method  B.  For analysis of the  nonglyco- 
sylated  heavy chain,  a  band  corresponding  to  ~27,000-30,000  daltons  was cut  out 
across  the  lanes  containing  immunoprecipitates  from  different  cell  lines.  The  IEF 
pattern of the nonglycosylated heavy chain (Fig.  7 B) demonstrates that no variability 
in pI can be detected  among the cell lines analyzed. 
Fig. 7 C  shows the IEF pattern of the nonglycosylated forms of the DR light chains. 
In this case a  band from ~26,000-29,000  daltons  (nonglycosylated light chain)  and a 
hand  from  29,000-32,000  daltons  (glycosylated  light  chain)  were  excised  from  the 
SDS-polyacrylamide  gel by method  B  and  applied  to the  IEF gel.  It is evident  that 
the  DR  light  chains  are  still  structurally  polymorphic  after  treatment  with  tunica- 
mycin. The light chains from the eight cell lines analyzed form four pI groups which 
are  defined  by  (a)  MADURA  (DRw8),  (b)  PRIESS  (DRw7),  MICH  (DRw5),  and 
MANN  (DRw7),  (c)  IBW4  (DRwl)  and  MST  (DRw2),  and  (d)  LKT  (DRw3)  and 
ARENT  (DRw6).  Within  each  group  the  DRw  specificities  are serologically  cross- 
reactive  (5).  However,  not  all  cross-reactive specificities  show  structural  similarities. 
For  example,  DRw2  and  6  are  strongly  cross-reactive  serologically,  but  their  light 
chains have very different  pI. It is apparent  from Fig.  7 that the nonglycosylated DR 
Ftc.  4.  Fluorographs of one-dimensional and 2-D gels of neuraminidase-treated  DR antigens. (A) 
Labeled cell extracts were incubated  at 37°C in the presence (+) or absence (-) of neuraminidase 
followed by immunoprecipitation  with anti-p29,34 serum and analysis by SDS-PAGE. (B) 2-D gel 
of samples from (A). Lane l is actin. Lanes 2-5 are DR light chains and lanes 6-11 are DR heavy 
chains incubated with (+) or without (-) neuraminidase. The cell lines used were MADURA (lanes 
2, 3, 6, 7), LKT (lanes 4, 5, 8, 9), and MST (lanes 10, 11). The concentration of ampholytes was 2% 
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FIG.  5.  Fluorograph  of SDS-polyacrylamide gel of DR  antigens from  normal  or tunicamycin- 
treated cells.  Lanes  1-3  are immunoprecipitates from an  untreated, labeled PRIESS cell extract 
using anti-p29,34 (lane 1), anti-p29 (lane 2), or anti-p34 (lane 3) sera. Lanes 4-15 are immunopre- 
cipitates from NP-40 extracts of tunicamycin-treated cells using anti-p29,34  (lane 4, 6),  anti-p29 
(lane 5, 7), or anti-p34 (lanes 8-15) sera. The cell lines used were IBW4 (lanes 4-8), MST (lane 9), 
LKT  (lane  10),  PRIESS  (lane  11), MICH  (lane  12), ARENT  (lane  13), MANN  (lane  14),  and 
MADURA (lane 15). Lanes 6-15 were exposed twice as long as lanes 1-5. Lanes 4 and 6 and lanes 
5 and 7 are equivalent. 
FiG.  6.  Fluorograph of SDS-polyacrylamide gel of DR antigens from normal  (lanes 15,  16)  and 
tunicamycin-treated  (lanes  1-14)  cells.  Cell  extracts  were  immunoprecipitated  with  anti-p29,34 
serum (lanes 1, 3, 5, 7, 9,  11,  13,  15) or anti-p29 serum (lanes 2, 4, 6, 8,  10,  12,  14,  16). The cell lines 
used were MST (lanes  1, 2),  LKT (lanes 3, 4),  PRIESS  (lanes 5, 6), MICH  (lanes 7, 8), ARENT 
(lanes 9,  10), MANN (lanes 11,  12), and MADURA (lanes 13-16). DEBORAH A.  SHACKELFORD AND JACK L. STROMINGER  157 
heavy and light chains of each specificity still display microheterogeneity. The bands 
of each  doublet  are  separated  by  0.1-0.2  pH  units.  Other  minor  bands  are  also 
apparent  upon  close  inspection.  The  source of this  heterogeneity is  being  further 
investigated. 
Discussion 
The data presented in this paper demonstrate that the light chains of DR antigens 
which differ serologically are structurally polymorphic. However, no definable differ- 
ences were detected among the DR heavy chains. These results agree with those of 
Silver and Ferrone (32) who compared the [~H]phenylalanine-labeled tryptic peptides 
of DR antigens from the B cell lines Victor (DRw4,6)  and WIL 2 (DRw4,7). IEF of 
the peptides revealed major similarities  in  the  heavy (a)  chains,  whereas the  light 
(,8) chains were strikingly different. These results have been confirmed and extended 
by comparison of the tryptic peptide maps of DR antigens from four other cell lines 
using  ion  exchange  chromatography  (J.  F.  Kaufman,  R.  A.  Andersen,  and J.  L. 
Strominger. Manuscript in preparation.). The lysine-labeled peptides of the DR heavy 
chains were virtually identical whereas the peptides of different DR light chains were 
dissimilar. 
Contrary results were reported by Klareskog et al. (33) who found more structural 
variation in the heavy chains than in the light chains. This was based on a comparison 
by high pressure liquid chromatography (HPLC) of the [3H]tyrosine-labeled tryptic 
peptides of DR  antigens  from the cell lines  Daudi  (DRw6,  unidentified)  and  Raji 
(DRw3,6). The source of the discrepancy is not apparent. 
This analysis of the variability of the DR subunits was undertaken to determine 
the relationship of protein structure to the serological polymorphism of HLA-DR in 
the human population. As demonstrated in this study, the DR light chains from cell 
lines with the same DR type exhibited the same 2-D pattern, whereas the light chains 
of different DRw  specificities showed different patterns.  These findings were inde- 
pendent of the HLA-A, -B, and -C type but correlate with the HLA-D/DR region 
type.  Furthermore,  some  serologically  cross-reactive  DR  types  generally  showed 
related  2-D  gel  patterns  of their  light  chains,  although  this  correlation  was  not 
absolute. Because limited or no structural polymorphism has been demonstrated for 
the  DR  heavy chain,  the structural  polymorphism observed here for the DR  light 
chain may be the basis of the serologically detected polymorphism. 
Other approaches to answer the question of which DR subunit carries the alloan- 
tigenic determinants have generally led  to ambiguous conclusions.  In these studies 
the  DR  chains were separated  and  independently reacted with  alloantisera  or xe- 
noantisera. Generally, xenoantisera recognized both subunits although the degree of 
binding varied. Snary et al. (34) reported preferential precipitation of the light chain 
with  xenoantiserum.  However, other laboratories  (33,  35,  36)  were able  to bind  a 
proportion  of heavy  chain  as  well  as  light  chain.  An  early  report  using  human 
alloantisera found preferential binding to the small subunit (36). Recently, Tosi et al. 
(35) found no significant binding of the heavy chain to alloantisera, whereas the light 
chain  was  recognized by  some  sera  with  a  maximum  binding  of 20%.  However, 
Klareskog  et  al.  (33)  reported  the  opposite  results.  As  a  result  of the  extensive 
denaturing conditions used  (SDS,  56°C, or urea)  in  most  of the experiments cited 
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not carry an alloantigenic determinant. A different approach was taken by Barnstable 
et al.  (37)  who studied the expression of DR antigens on  human-mouse  somatic cell 
hydrids. In their study, the hybrids did not react with xenogeneic DR antiserum but 
a  few clones did react with alloantisera by immunofluorescence. Because the xenoan- 
tiserum  reacted  predominantly  with  the  small  subunit,  they  concluded  that  the 
hybrids lacked the light chain, and  that  the alloreactivity was a  result of expression 
of the large subunit.  However, they did not show  that  the alloantisera did, in  fact, 
bind to a  DR heavy chain. 
Most studies investigating the alloantigenic determinants of the DR and Ia mole- 
cules  have  concluded  that  the  protein  and  not  the  carbohydrate  portion  of  the 
molecule determines alloreactivity. Enzymatic removal of the glycan chains from the 
DR subunits leaves the alloantigenic activity intact (38). Similar studies on the murine 
Ia molecule have shown  that  after removal of the carbohydrate, the two chains are 
still precipitable with  alloantisera, whereas  digestion of the  molecule with  pronase 
yields glycopeptides which do not appear to bind alloantibody (39). The present study 
supports the conclusions of these studies because  it was  demonstrated  that  the  DR 
light chains are still structurally polymorphic despite the removal of sialic acid or N- 
linked  oligosaccharide.  Preliminary  evidence  also  indicates  that  the  tunicamycin- 
treated  DR  molecules are precipitable with  alloantisera  ([40],  H.  Ploegh.  Personal 
communication.).  However,  tunicamycin  only  prevents  the  addition  of N-linked 
oligosaccharide to  protein.  Nishikawa  et  al.  (41)  found  that  although  tunicamycin 
treatment of a  B-cell line reduced the molecular weights of the DR  heavy and light 
chains,  consistent  with  the  removal  of a  glycan  chain,  the  cells were  still  able  to 
incorporate  [3H]glucosamine  into  the  large subunit.  This  observation  suggests  that 
the heavy chain  may contain  another  type of oligosaccharide in  addition to  an  N- 
linked one. 
The 2-D gel pattern of the DR heavy chain observed in this study is similar to that 
observed by Ikeman et al. (42) who reported that the large subunit from different cell 
lines  all  focused  as  a  cluster  of  four  spots  within  a  pH  range  of  5.3-5.4  and 
corresponding to a  mol wt of 33,000. The antigens isolated from chronic lymphocytic 
leukemia cells showed additional, more basic spots at a  higher molecular weight, but 
it was not demonstrated that these represent heavy chain variants. Springer et al. (19) 
reported that the DR heavy and light chains isolated from the cell line 4265  had pI 
of 5.2  and  6.1,  respectively. In  this study, the pI  assigned to the various bands  are 
tentative because it was not  determined if the proteins had  reached an equilibrium 
position. The pI are reported to facilitate comparisons. 
Fie.  7.  Fluorograph of 2-D gels of DR heavy and light chains from tunicamycin-treated  cells. (A) 
2-D gel showing the glycosylated DR heavy (34,000 mol wt) and light (31,000 mol wt) chains and 
the nonglycosylated heavy (29,000 mol wt) and light (27,000 mol wt) chains. The NP-40 extracts of 
tunicamycin-treated  PRIESS cells were immunoprecipitated with anti-p29,34 serum. A single lane 
from the SDS gel was excised and analyzed on the IEF gel. The proportions of ampholytes used 
were the same as given in Fig. 3. (B) 2-D gel of nonglycosylated DR heavy chains isolated with anti- 
p34 serum from extracts of tunicamycin-treated  cells. The cell lines used were MADURA (lane 1), 
MANN (lane 2), ARENT (lane 3), MICH (lane 4), PRIESS (lane 5), LKT (lane 6), MST (lane 7), 
and IBW4 (lane 8). The IEF gel contained  2% (wt/vol)  ampholytes composed of 40% pH 3.5-10 
and 60% pH 4-6 Ampholines. (C) 2-D gel of glycosylated (lane 1) and nonglycosylated (lanes 2-9) 
DR light chains isolated with anti-p29 serum. The cell lines are IBW4 (lane 2), MST (lane 3), LKT 
(lane 4), PRIESS  (lanes 1, 5), MICH (lane 6), ARENT (lane 7), MANN (lane 8), and MADURA 
(lane 9). The IEF gel contained  2% (wt/vol) ampholytes composed of 40% pH 3.5-10 and 60% pH 
6-8 Ampholines. MW, molecular weight. 160  STRUCTURAL POLYMORPHISM OF  HLA-DR ANTIGENS 
IEF of the heavy and light chains of DR and Ia molecules has revealed that both 
subunits  of a  given specificity display microheterogeneity  (15,  42-44).  In this study 
and those cited above, the heterogeneity does not appear to be a result of artifactual 
modifications such as deamidation, carbamylation, or oxidation.  The urea solutions 
used in this study were freshly prepared and deionized to remove cyanate ions which 
can cause carbamylation (45).  The presence of the ampholytes also generally protects 
proteins from this type of modification (46).  Carbamylation does not appear to occur 
when the gel pieces are equilibrated in urea and NP-40 because the DR heavy chain 
focuses as three to four bands even when this process is omitted. The proteins could 
be  oxidized  by  the  ammonium  persulfate  in  the  first  dimension.  However,  actin 
focuses as two major bands as has been observed in O'Farrell 2-D gels (46)  in which 
IEF is the first dimension and SDS-PAGE the second (28).  The DR and Ia heavy and 
light chains also appear as multiple spots in O'Farrell 2-D gels (15, 42, 43). Oxidation 
in the IEF gel does not seem to occur because the protein standards focus as reported 
elsewhere (47)  and prerunning the gel does not reduce the number of bands. 
The basis of the microheterogeneity within  a  DRw specificity remains to be fully 
explained.  Sialic  acid  heterogeneity accounts  for some of the  bands,  but  even after 
removal of most of the carbohydrate,  the heavy and light  chains each  focus as two 
major bands.  Accumulating evidence suggests that  there  may be a  second  DR-like 
antigen  in  man  (48,  49).  Several  laboratories have mapped a  second  B-cell specific 
antigen to the right of the HLA-B locus, perhaps between the HLA-A and -B loci (49, 
50).  It  is now being investigated whether  the  multiple  bands  observed  for the  DR 
subunits  represent  the  products  of multiple  loci  or post-translational  or artifactual 
modifications of one product. One possibility is phosphorylation heterogeneity. It has 
been demonstrated that the HLA-A and -B heavy chains are phosphorylated in vivo 
(51)  and it has also been shown that at least the DR heavy chain can be phosphoryl- 
ated (40).  As noted earlier, it is also possible that the large DR subunit  may contain 
two types of oligosaccharide (41). 
In addition  to  the  heavy and  light  chains,  DR  immunoprecipitates contain  two 
other polypeptides designated M 1 and M2. It has not been determined whether these 
proteins are MHC-encoded or whether they are part of the native DR complex. Both 
proteins were invariant by IEF in all cell lines analyzed. One of the polypeptides may 
be identical to the one described by Giphart et al. (52).  The M1  and M2 proteins do 
not  appear to  be directly  recognized  by the  anti-29,34  serum  because  they can  be 
largely dissociated from the DR complex by incubation  at 37°C  or by washing the 
SaCI-bound immunoprecipitate with 0.1% SDS which does not dissociate the rest of 
the immune complex. Studies using the cross-linking reagent dimethyl 3,3'-dithiobis- 
propionimidate (19,  53)  or tartryl bis(glycylhydrazine) (54)  have shown that the DR 
and Ia antigens exist as a  dimer of heavy and light chain  in solution.  Dancey et al. 
(53)  have further shown that the murine I-E/C antigen exists as a  dimer on the cell 
surface and is not cross-linked to other cellular components.  These findings suggest 
that other proteins, such as M1  and M2, are not part of the DR complex. However, 
not all of the I-E/C antigens were cross-linked at the concentrations of DTBP used 
and extensively cross-linked proteins may not have been detergent solubilized (53).  In 
addition, the gel systems used may not have resolved M 1 from the heavy chain. The 
M1  protein  may be an intracellular  protein which  associates with  the  DR complex 
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when the antibody is incubated with intact cells (Fig. 2).  An analogous protein has 
been described in the murine system (55). An invariant basic protein of 31,000 mol wt 
appeared  in  all  immunoprecipitates  of murine  I-A and  I-E/C  subregion  products. 
This protein, Ii, was not labeled with 1125 using lactoperoxidase, also suggesting that 
it may be intracellular (55). 
The human  DR antigens have been demonstrated to be homologous in structure 
and function to the Ia antigens of the mouse and guinea pig. The strongest homology 
has been observed between the human  DR and the murine I-E/C antigens in terms 
of serological  cross-reactivity  and  (56,  57)  and  N-terminal  amino  acid  sequence 
homology (1). Analyses of the tryptic peptides of I-E/C heavy (a) and light (fl) chains 
demonstrated that most of the structural variability between different allelic products 
is  in  the /~  subunit  (58-60).  The /~-chain  from  different  genotypes shared  on  the 
average 50% of their peptides, whereas the a-chains shared 90% (58). The Ia antigens 
of mouse and guinea pig have also been analyzed by IEF (15,  16, 43, 44). As with the 
human DR antigens, the heavy chain was acidic whereas the light chain was neutral 
to basic. Both subunits of a given genotype and subregion appeared as multiple spots, 
but  it  was  predominantly  the  light  chain  that  showed  structural  polymorphism 
between genotypes (15). 2-D gel and peptide map analyses indicated that both I-E/C 
subunits are MHC-controlled, but although the a-chain maps to the I-E/C subregion, 
the fl-chain maps to I-A (15, 61, 62). The I-A a- and fl-chains both appear to map to 
the I-A subregion and exhibit considerable structural polymorphism by peptide map 
analysis (17, 63). 
The data presented in this paper demonstrate that, analogous to the murine I-E/C 
antigens,  the  light  chains of the  human  DR  antigens  are structurally polymorphic 
and  appear  to  be  controlled  by  the  HLA-D/DR  region.  No  polymorphism  was 
detected among the DR heavy chains and it can not be concluded if they are MHC- 
encoded. The I-E/C  heavy chains only showed limited  differences as measured by 
peptide map analysis which tends to overestimate differences. 
An antigen analogous to the murine I-A (or I-J) subregion antigens has not been 
identified in man. In this study, the nonglycosylated forms of the DR heavy and light 
chains  each  focused as  two  major bands  which  could  indicate  that  there  are  two 
nonallelic DR antigens.  However, other interpretations are possible. Further sthdies 
of the genetics, serology, and biochemistry of the HLA-D/DR region and its products 
should disclose if multiple loci do, in fact, exist. 
Summary 
Human HLA-DR antigens were immunoprecipitated from Nonidet P-40 extracts 
of [3SSlmethionine-labeled  B  lymphoblastoid  cell  lines  and  compared  by  sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and isoetectric focus- 
ing  (IEF).  Two-dimensional  (2-D)  gel  analyses,  combining SDS-PAGE  in  the  first 
dimension  and  IEF in the second dimension, revealed that  the heavy (a)  and  light 
(fl) chains of each DRw specificity displays microheterogeneity of charge. However, 
the  pattern of the heavy chain  did  not  vary among different  DRw  specificities. In 
contrast, the light  chains of different DRw  types varied both  in  apparent  size and 
charge  distribution.  Removal  of sialic  acids  with  neuraminidase  or  inhibition  of 
glycosylation with tunicamycin reduced the microheterogeneity of both DR subunits. 
Howeve,', the heavy and light chains each still focused as two major bands, suggesting 162  STRUCTURAL POLYMORPHISM OF HLA-DR  ANTIGENS 
that  other  post-translational  modifications  contribute  to  the  microheterogeneity  or 
that  there  are  two nonallelic  DR-like  molecules.  After treatment  with either  neura- 
minidase  or tunicamycin,  the  DR  light  chains,  but  not  the  heavy chains,  were still 
structurally polymorphic. The DR light chains of serologically cross-reactive specific- 
ities  displayed similar  2-D gel patterns  suggesting that  the structural  polymorphism 
of the DR light chains is the basis for the serologically detected polymorphism of the 
HLA-DR antigens. 
Two additional polypeptides were observed in immunoprecipitates of DR antigens. 
These proteins,  designated  M1  and M2, both had a  basic isoelectric point  and were 
invariant  among different cell lines.  The protein  M1  may be intracellular  because it 
can not be immunoprecipitated  from the cell surface. 
The  helpful  criticisms  and  suggestions  of the  members  of this  laboratory  are  gratefully 
acknowledged. 
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